FDA Drug Application (021515) for WELLBUTRIN XL by VALEANT INTL

Back to FDA Applications sponsored by VALEANT INTL

Application Number021515
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameWELLBUTRIN XL
Active IngredientBUPROPION HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROCHLORIDE7


Back to FDA Applications sponsored by VALEANT INTL